Searched for
DAPAGLIFLOZIN TABLETS
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- Stocks in news: Torrent Power, GAIL, J&K Bank, Ola Electric, Vedanta, InfosysMarkets ended higher for the third consecutive session amidst volatility. Today's trade will focus on ceasefire developments and the MPC me...
- Zydus Lifesciences hits the sweet spot after approval for generic diabetes drugZydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozin Tablets. Designed...
- Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in ChinaIndian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health mi...
- Stocks in news: Dabur, Grasim, Lupin, RBL Bank, Waaree Renewable TechGrasim Industries said that it will issue shares on a rights basis at Rs 1,812 per share and has set January 10 as the record date.
- Glenmark launches triple-drug combo for type 2 diabetesGlenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, whic...
- AstraZeneca gets GCGI approval to import heart failure drugAstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatme...
- NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
- NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
- Glenmark Pharma launches drug for diabetic patients with comorbiditiesThe new drug is well researched and affordable fixed-dose combination, which will significantly improve glycemic control in adult patients,...
- Astrazeneca gets marketing authorisation to use anti-diabetes drug for kidney diseaseThe drug is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment...
- AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney diseaseThe company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets...
- Zydus Healthcare launches generic anti-diabetic Dapagliflozin tablets in IndiaThe once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes...
- Trending stocks: AstraZeneca Pharma shares gain over 1%A total of 1,321 shares changed hands on the counter till 11:40AM (IST).
- Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tabletsGlenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin an...
- Natco launches cut-price copies of AstraZeneca's patented anti-diabetes drugThe launch gives Natco an entry in the rapidly growing SGLT-2 segment that has mostly been dominated by global drug makers. However, for ro...
- Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
- Alembic Pharma gets tentative nod from USFDA for glycemic control drugQuoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending D...
- AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
Load More
